Immix Biopharma Inc. (IMMX:NASDAQ) soared at $2.39, a gain of 29.2%. On Wed, Jun 01, 2022, IMMX:NASDAQ touched a New 2-Week Low of $1.85. The stock got featured on our News Catalysts scanner on Sat, May 21, 2022 at 09:39 AM in the 'MISCELLANEOUS' category. From Thu, May 19, 2022, the stock recorded 62.50% Up Days and 55.56% Green Days
The stock spiked on Thu, May 26, 2022 at $3.45 with a volume of 2M+.
About Immix Biopharma Inc. (IMMX:NASDAQ)
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation.
Top 10 Gainers:
- NRX Pharmaceuticals Inc. (NRXP:NASDAQ), 47.48%
- Repare Therapeutics Inc. (RPTX:NASDAQ), 44.8%
- Esports Technologies Inc. (EBET:NASDAQ), 33.58%
- Immix Biopharma Inc. (IMMX:NASDAQ), 29.19%
- Credo Technology Group Holding Ltd (CRDO:NASDAQ), 26.24%
- Chewy, Inc. (CHWY:NYSE), 24.22%
- Integrated Media Technology Limited (IMTE:NASDAQ), 23.69%
- The Singing Machine Company Inc. (MICS:NASDAQ), 22.54%
- Spruce Biosciences Inc. (SPRB:NASDAQ), 20.55%
- PyroGenesis (PYR:NASDAQ), 19.92%